发明名称 |
Indirubin-3′-oxime derivatives as potent cyclin dependent kinase inhibitors |
摘要 |
The present invention relates to an indirubin-3′-oxime derivative as potent cyclin dependent kinase inhibitor with anti-cancer activity. More particularly, this invention relates to an indirubin-3′-oxime derivative as potent cyclin dependent kinase inhibitor having excellent anti-cancer activity against human lung cancer cell, human fibro sarcoma cell, human colon cancer cell, human leukemia cell, human stomach cancer cell, human nasopharyngeal cancer cell and/or human breast cancer cell. |
申请公布号 |
US8859783(B2) |
申请公布日期 |
2014.10.14 |
申请号 |
US201113576105 |
申请日期 |
2011.01.28 |
申请人 |
Anygen Co., Ltd. |
发明人 |
Kim Yong-Chul;Kim Jae-Il;Ban Soo-Ho;Jeong Soon-Young;Choi Soo-Jeong;Lee Jung-Eun |
分类号 |
C07D209/38;A61K31/404;C07D403/04 |
主分类号 |
C07D209/38 |
代理机构 |
Kenyon & Kenyon LLP |
代理人 |
Kenyon & Kenyon LLP |
主权项 |
1. An indirubin-3′-oxime derivative compound as cyclin dependent kinase inhibitor represented by formula (I) wherein i) R1 is OH and R2 is NO2; ii) R1 is F and R2 is NO2; iii) R1 is OH and R2 is Cl; or iv) R1 is OH and R2 is F. |
地址 |
Jeollanam-Do KR |